In preparation for the winter season last year, the Korean Medical Association recommended that people with compromised immune systems receive both the flu and COVID-19 vaccines simultaneously. The prospect of receiving shots in both arms may have been a shock, especially for children. However, there is now exciting news about a multitasking substance capable of preventing and treating both flu and COVID-19 infections concurrently, and it is gaining momentum.
The researchers identify new drug candidates for preventing and treating major respiratory viral infections. This research has recently been published in the international journal Cell Reports Medicine.
In recent times, a global resurgence of infections has been observed, predominantly linked to a novel variant of COVID-19 known as ‘JN.1’. The Korean Disease Control and Prevention Agency reports that this variant has become the dominant strain in Korea, surpassing a detection rate of 50%. While vaccines prove effective against specific viruses, the emergence of new variants necessitates considerable time for the development of corresponding vaccines, leading to potential public health crises as witnessed during the COVID-19 pandemic. To address this challenge, there is a pressing need for more broadly applicable treatments capable of swiftly responding to the ongoing mutations.
The research team explored the potential application of the long-acting recombinant cytokine protein rhIL-7-hyFc (NT-I7; efineptakin alfa), currently undergoing clinical development as an immunotherapy drug. This exploration aimed to assess its suitability as a treatment for major respiratory viruses due to its capacity to activate diverse immune cells within the respiratory tract.
In experimental settings, the protein triggered the influx of acquired T cells and the proliferation of innate-like T cells in the lungs. These innate-like T cells demonstrated a swift and comprehensive defense against a broad spectrum of pathogens, functioning as if they were deploying inherent mechanisms. Consequently, the treatment exhibited both therapeutic and preventive effects against COVID-19, influenza virus, respiratory syncytial virus, and others. Notably, the drug candidates were not tailored to a specific virus but demonstrated universal applicability to major respiratory diseases.
The lead author of the study stated, "Through collaborative study involving industry, academia, and the research community, we have discovered insights to prepare for future respiratory virus pandemics.” The author added, “We are committed to advancing our efforts to transform the prospect of a universal treatment, capable of controlling co- and serial infections of respiratory viruses and bacteria, into a reality."
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(23)00579-7
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Ffc-fused-il-7-provides&filter=22
Addressing both flu and COVID-19 through a single, multitasking injection
- 446 views
- Added
Latest News
How the brain fine-tunes it…
By newseditor
Posted 25 Apr
Immune cells carry a long-l…
By newseditor
Posted 25 Apr
Mutations in noncoding DNA…
By newseditor
Posted 24 Apr
More influence of environme…
By newseditor
Posted 24 Apr
The assembly of the human c…
By newseditor
Posted 24 Apr
Other Top Stories
Connectomic mapping in the developing cortex
Read more
Epigenetic regulation of the development of growth hormone-releasin…
Read more
Neurodevelopmental changes in human brain organoids from Neandertha…
Read more
Mother's scent triggers face-selective neural responses in infants
Read more
Molecular atlas reveals how brain cells develop
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Partial loss of MCU mitigat…
By newseditor
Posted 27 Apr
Thiol dioxygenases: from st…
By newseditor
Posted 27 Apr
Systematic characterization…
By newseditor
Posted 27 Apr
The MYCN 50 UTR as a therap…
By newseditor
Posted 25 Apr
Control of neuronal excitat…
By newseditor
Posted 25 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar